Defining Hyperphagia for Improved Diagnosis and Management of MC4R Pathway-Associated Disease: A Roundtable Summary

Overview

Journal Curr Obes Rep

Date 2025 Jan 24

PMID 39856371

Authors

Steven B Heymsfield

Karine Clement

Beatrice Dubern

Anthony P Goldstone

Andrea M Haqq

Peter Kuhnen

Jesse Richards

Christian L Roth

Erica L T van den Akker

Martin Wabitsch

Jack A Yanovski

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Hyperphagia is a condition associated with rare obesity-related diseases, presenting as a pathologic, insatiable hunger accompanied by abnormal food-seeking behaviors. In October 2023, a group of researchers and clinicians with expert knowledge on hyperphagia convened at the annual ObesityWeek meeting to discuss the need for a unified definition of hyperphagia and key items necessary to improve the identification, assessment, and treatment of hyperphagia in patients with melanocortin 4 receptor (MC4R) pathway-associated diseases.

Recent Findings: The definition of hyperphagia proposed by this group is a pathologic, insatiable hunger accompanied by abnormal food-seeking behaviors. Suggested methods to accurately identify patients with hyperphagia include increased physician and parent/caregiver education and standardized efficient screening procedures for use in the clinic. The etiology of hyperphagia as related to abnormal MC4R signaling was also reviewed and proposed as a central cause of the condition across several underlying diseases. Given this potential unified underlying pathology, the expert group recommends that patients with hyperphagia undergo genetic testing and that treatment include comprehensive weight-management strategies incorporating lifestyle and pharmacotherapies targeted at addressing hyperphagia.

References

Mankad M, Gokhale D . Not Hungry, but Still Snacking: The Association Between Hedonic Hunger and Snacking Behaviour Among Young Adults in Vadodara, Gujarat. Cureus. 2023; 15(9):e44814. PMC: 10558963. DOI: 10.7759/cureus.44814. View

Kuhnen P, Clement K, Wiegand S, Blankenstein O, Gottesdiener K, Martini L . Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist. N Engl J Med. 2016; 375(3):240-6. DOI: 10.1056/NEJMoa1512693. View

Heisler L, Jobst E, Sutton G, Zhou L, Borok E, Thornton-Jones Z . Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron. 2006; 51(2):239-49. DOI: 10.1016/j.neuron.2006.06.004. View

Campos A, Cifuentes L, Hashem A, Busebee B, Hurtado-Andrade M, Ricardo-Silgado M . Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case-Control Study. Obes Surg. 2022; 32(8):2632-2640. PMC: 9721531. DOI: 10.1007/s11695-022-06122-9. View

Holsen L, Zarcone J, Brooks W, Butler M, Thompson T, Ahluwalia J . Neural mechanisms underlying hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring). 2006; 14(6):1028-37. PMC: 1535344. DOI: 10.1038/oby.2006.118. View

Manning K, Holland A . Puzzle Pieces: Neural Structure and Function in Prader-Willi Syndrome. Diseases. 2017; 3(4):382-415. PMC: 5548261. DOI: 10.3390/diseases3040382. View

Lawson J, Wiedemann A, Carr M, Kerrigan S . Considering Food Addiction through a Cultural Lens. Curr Addict Rep. 2021; 7(3):387-394. PMC: 8320638. DOI: 10.1007/s40429-020-00315-x. View

Tomlinson J . Bardet-Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction. Diabetes Obes Metab. 2024; 26 Suppl 2:13-24. DOI: 10.1111/dom.15480. View

Dykens E, Maxwell M, Pantino E, Kossler R, Roof E . Assessment of hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring). 2007; 15(7):1816-26. DOI: 10.1038/oby.2007.216. View

10.

Muller H, Tauber M, Lawson E, Ozyurt J, Bison B, Martinez-Barbera J . Hypothalamic syndrome. Nat Rev Dis Primers. 2022; 8(1):24. DOI: 10.1038/s41572-022-00351-z. View

11.

Stunkard A, Messick S . The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985; 29(1):71-83. DOI: 10.1016/0022-3999(85)90010-8. View

12.

Proenca da Fonseca A, Mastronardi C, Johar A, Arcos-Burgos M, Paz-Filho G . Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies. J Diabetes Complications. 2017; 31(10):1549-1561. DOI: 10.1016/j.jdiacomp.2017.04.026. View

13.

Kalm L, Semba R . They starved so that others be better fed: remembering Ancel Keys and the Minnesota experiment. J Nutr. 2005; 135(6):1347-52. DOI: 10.1093/jn/135.6.1347. View

14.

Russell H, Oliver C . The assessment of food-related problems in individuals with Prader-Willi syndrome. Br J Clin Psychol. 2003; 42(Pt 4):379-92. DOI: 10.1348/014466503322528928. View

15.

Zorn S, von Schnurbein J, Schirmer M, Brandt S, Wabitsch M . Measuring hyperphagia in patients with monogenic and syndromic obesity. Appetite. 2022; 178:106161. DOI: 10.1016/j.appet.2022.106161. View

16.

Clement K, van den Akker E, Argente J, Bahm A, Chung W, Connors H . Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 2020; 8(12):960-970. DOI: 10.1016/S2213-8587(20)30364-8. View

17.

Blundell J, Finlayson G . Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption?. Physiol Behav. 2004; 82(1):21-5. DOI: 10.1016/j.physbeh.2004.04.021. View

18.

Huvenne H, Dubern B, Clement K, Poitou C . Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016. Obes Facts. 2016; 9(3):158-73. PMC: 5644891. DOI: 10.1159/000445061. View

19.

Zhao S, Kanoski S, Yan J, Grill H, Hayes M . Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner. Int J Obes (Lond). 2012; 36(12):1522-8. PMC: 3335926. DOI: 10.1038/ijo.2011.265. View

20.

Emet D, Ozon A, Alikasifoglu A, Kandemir N, Gonc N . Alpha-Melanocyte-Stimulating Hormone is Elevated in Hypothalamic Obesity Associated with Childhood Craniopharyngioma. Obesity (Silver Spring). 2021; 29(2):402-408. DOI: 10.1002/oby.23087. View